William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
-
Accelerate Diagnostics (AXDX) Announces Proposed Stock Offering
-
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
-
Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022
-
Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021
-
Accelerate Diagnostics to Present at the William Blair Growth Stock Conference on June 6, 2019
-
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
-
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
-
Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
-
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
-
Accelerate Diagnostics (AXDX) Prices 2.75M Upsized Offering at $28.85/Sh
-
Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
-
Accelerate Diagnostics (AXDX) Commences 2.5M Offering of Common Stock
-
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
-
Unusual 11 Mid-Day Movers 6/15: (HMNY) (AEGR) (PN) Higher; (CBYL) (LBIX) (IDN) Lower
-
Accelerate Diagnostics (AXDX) Gains Sharply Following William Blair Conference Presentation
-
Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference
-
Accelerate Diagnostics to Present at the 36th Annual Growth Stock Conference
-
William Blair Starts Accelerate Diagnostics (AXDX) at Outperform
-
Accelerate Diagnostics Completes $109 Million Offering, Underwriters Exercise in Full Their Option to Purchase Additional Shares
-
Accelerate Diagnostics (AXDX) Prices 5.59M Common Stock Offering at $17/Share
-
Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
-
Accelerate Diagnostics (AXDX) Announces $80M Common Stock Offering
-
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock

